Anzeige
Mehr »
Mittwoch, 04.03.2026 - Börsentäglich über 12.000 News
60.000 USD pro Tonne! Entsteht hier der nächste Gewinner im Antimon-Boom?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
236 Leser
Artikel bewerten:
(1)

RNAConnect: First-of-Its-Kind Study Characterizing the Mechanism of Template Switching With Ultraprocessive Reverse Transcriptase Enzymes

BRANFORD, CT / ACCESSWIRE / August 27, 2024 / A new study demonstrates a significant advancement in our understanding of the template switching mechanism of reverse transcriptases (RTs) that is widely adopted to streamline RNA sequencing library preparation. The paper, Characterization and implementation of the MarathonRT template-switching reaction to expand the capabilities of RNA-Seq, just published in the RNA Society journal RNA, details the use of the UltraMarathonRT® (uMRT) enzyme and its progenitor, the MarathonRT®, to enhance the accuracy and efficiency of RNA sequencing, particularly for long or structured RNA transcripts. This breakthrough provides researchers with a powerful tool for capturing complete RNA sequences, offering deeper insights into RNA biology and expanding the potential for RNA research.

The study dissects the mechanisms behind template-switching reactions of RT enzymes used in RNA sequencing, a critical step for capturing full-length RNA sequences. Traditional methods have relied on distributive short-read RTs, such as MMLV RT enzymes. However, these methods have significant limitations due to the underpowered RT enzymes. The research, led by RNAConnect's scientific co-founders, introduces a novel approach by adapting ultraprocessive RTs, derived from group II self-splicing introns, for use in RNA sequencing. The study provides a comprehensive understanding of the nucleotide specificity and the template-switching efficiency of the MarathonRT enzymes.

"This study represents a major milestone for RNA sequencing technology," said Li-Tao Guo, co-founder and VP of R&D at RNAConnect. "By leveraging the unique properties of our flagship product UltraMarathonRT, the team has described a more accurate and efficient method for RNA sequencing. This not only enhances our ability to analyze long and complex RNA molecules, but also opens new avenues for discovering RNA variants that were previously undetectable with conventional methods. Our goal is to continue pushing the boundaries of RNA research to unlock new insights into the complexities of RNA biology."

The new UltraMarathonRT-facilitated sequencing pipeline allows for the rapid and accurate sequencing of complex RNA libraries, including mixtures of long RNA transcripts. This method has been validated using both total human RNA and poly(A)-enriched RNA, showcasing its versatility and robustness in various RNA-seq applications. By optimizing each step of the RNA sequencing process from enzymatic reactions to template-switching oligonucleotide design, the study lays the foundation for a new era of RNA research, empowering scientists to explore the full diversity of RNA sequences and structures with unprecedented precision.

UltraMarathonRT Template Switching Kits designed to build RNA sequencing libraries based on this technology are available at www.rnaconnect.com.

About UltraMarathonRT Template Switching Kit:

The uMRT Template Switching Kit can provide full-length cDNAs in a simple reaction even when you do not know the sequences at the 5' end of the RNA transcript. Its terminal transferase activity allows for template switching when used with the uMRT Template Switching Oligonucleotide.

It is designed to capture low-abundance RNA with high efficiency and sensitivity. Kit components include uMRT, uMRT Buffer, uMRT Boost, uMRT Template Switching Oligonucleotide and the Template Switching Buffer.

About RNAConnect:

RNAConnect was founded by innovators in the RNA community, for innovators in the RNA community. By providing better enzymatic tools for visualizing and manipulating RNA, we can help our community discover, create, and innovate in ways previously not possible. For more information about RNAConnect and its offerings, to share your own ideas or to place your first order of uMRT, visit www.rnaconnect.com.

Contact Information

Andrew Bond
CCO
info@rnaconnect.com
475-338-2014

SOURCE: RNAConnect

.

View the original press release on newswire.com.

© 2024 ACCESS Newswire
Tech-Aktien schwanken – 3 Versorger mit Rückenwind
Die Stimmung an den Märkten hat sich grundlegend gedreht. Während Tech- und KI-Werte zunehmend mit Volatilität und Bewertungsrisiken kämpfen, erleben klassische Versorger ein unerwartetes Comeback. Laut IEA und EIA steigt der globale Strombedarf strukturell weiter, nicht nur wegen E-Mobilität und Wärmepumpen, sondern vor allem durch energiehungrige KI-Rechenzentren. Energie wird damit zur zentralen Infrastruktur des digitalen Zeitalters.

Gleichzeitig rücken in unsicheren Marktphasen stabile Cashflows, solide Bilanzen und regulierte Renditen wieder stärker in den Fokus. Genau hier spielen Versorger ihre Stärken aus: berechenbare Erträge, robuste Nachfrage und hohe Dividenden – Qualitäten, die vielen Wachstumswerten aktuell fehlen.

Nach Jahren im Schatten der Tech-Rallye steigt nun das Interesse an Unternehmen, die Stabilität mit langfristigen Wachstumsthemen wie Netzausbau, Dekarbonisierung und erneuerbaren Energien verbinden.

Im aktuellen Spezialreport stellen wir drei Versorger vor, die defensive Stärke mit attraktivem Potenzial kombinieren.

Jetzt den kostenlosen Report sichern – bevor die nächste Versorgerwelle Fahrt aufnimmt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.